Has Monika Singhal, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,583 in general payments to Monika Singhal, MD across 72 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Monika Singhal, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Monika Singhal, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Monika Singhal, MD

Psychiatry · Longview, TXNPI 1306938410

Payments from drug & device makers

$1,583in general payments, 2019–2025

Across 72 payments — averaging $21.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sunovion Pharmaceuticals Inc.$583
Teva Pharmaceuticals USA, Inc.$303
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$256
Otsuka America Pharmaceutical, Inc.$133
Takeda Pharmaceuticals U.S.A., Inc.$89
Merck$45
plus $175 from 7 others

What the payments were for

Food & beverage$1,53197%
Education$533%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sunovion Pharmaceuticals Inc.	31	$583
Teva Pharmaceuticals USA, Inc.	7	$303
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	10	$256
Otsuka America Pharmaceutical, Inc.	7	$133
Takeda Pharmaceuticals U.S.A., Inc.	5	$89
Merck	3	$45
Neurocrine Biosciences, Inc.	2	$42
Eisai Inc.	1	$41
AbbVie	2	$23
E.r. Squibb & Sons, L.L.C.	1	$20
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$18
Johnson & Johnson	1	$16
Vanda Pharmaceuticals Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AUSTEDO$219

How this compares

$1,583 in reported general payments places this provider in the 75th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas →

Medicare billing

Part B allowed, 2024

$38,502

Medicare patients

Services billed

383

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
AplenzinBupropion Hbr	11	$21,173
Lurasidone Hcl	38	$20,819
Ziprasidone Hcl	27	$4,642
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	47	$4,533
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	31	$3,130
Quetiapine Fumarate	83	$2,624
Alprazolam	382	$2,440
Bupropion XlBupropion Hcl	81	$2,434
Aripiprazole	28	$2,143
Duloxetine Hcl	124	$2,002
Divalproex Sodium ErDivalproex Sodium	16	$1,910
Lamotrigine	86	$1,684
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	48	$1,407
Clonazepam	223	$1,262
Venlafaxine Hcl ErVenlafaxine Hcl	56	$1,184

Paid to pharmacies, not to this prescriber.

Other psychiatry in Longview

Jonathan LockhartLongview$765K
Scott BartleyDallas$42.7M
David BrownAustin$15.8M
Rajinder ShiwachDesoto$15.4M
Darin OkudaDallas$14.7M
Jason MensahBeaumont$10.3M
Michael DowningDallas$7.6M
Rakesh JainLake Jackson$7.2M
Suresh SureddiPlano$5.9M
Marshall LucasThe Woodlands$4.8M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →